DuPont Considering Sale of Solae

DuPont may sell its 72% stake in Solae, the company’s soy-based chemicals joint venture with Bunge, DuPont executive v.p. Mark Vergnano recently told Bloomberg (New York). The business, which  has reportedly received offers from DSM and Tate & Lyle, posts annual Ebitda of $180 million. DuPont chair and CEO Ellen Kullman has previously said the Solae business has several synergies with its recent Danisco...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers